testosterone

Women’s Testosterone Prescriptions Rise 146%, FDA Review Planned

The FDA is reviewing the evidence on testosterone therapy for menopausal women as off-label use rises without an approved product, amid safety concerns and calls for standardized dosing. Meanwhile, prescriptions have surged, but patients face pharmacy delays and coverage gaps, with medical groups limiting use to women with hypoactive sexual desire disorder and researchers preparing a public workshop to assess safety and efficacy.